Leflunomide (HWA 486) inhibits experimental autoimmune tubulointerstitial nephritis in rats

This publication has 23 references indexed in Scilit:

• Effects of cyclosporin A on the development of immune-mediated interstitial nephritis
  Kidney International, 1988
• Induction, characterization, and cell transfer of autoimmune tubulointerstitial nephritis
  Kidney International, 1987
• The use of the murine chronic graft Vs host (CGVH) disease, a model for systemic lupus erythematosus (SLE), for drug discovery
  Inflammation Research, 1987
• Disease modifying activity of HWA 486 in rat adjuvant-induced arthritis
  Inflammation Research, 1987
• Inhibition of the neutrophilic infiltrate of experimental tubulointerstitial nephritis in the Brown-Norway rat by decomplementation
  Clinical Immunology and Immunopathology, 1987
• Disease modifying activity of HWA 486 on the development of SLE in MRL/1-mice
  Inflammation Research, 1986
• Immunopharmacological profile of HWA 486, a novel isoxazol derivative— II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone, or cyclosporin A
  International Journal of Immunopharmacology, 1986
• Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity — I. Disease modifying action on adjuvant arthritis of the rat
  International Journal of Immunopharmacology, 1985
• Autoimmune cell-mediated tubulointerstitial nephritis induced in lewis rats by renal antigens
  Clinical Immunology and Immunopathology, 1980
• Transfer of Experimental Autoimmune Renal Cortical Tubular and Interstitial Disease in Guinea Pigs by Serum
  Science, 1973